Long‐Term Outcomes and Predictors of Delayed Steroid Initiation in Type 1 Autoimmune Pancreatitis Initially Managed Without Corticosteroids
Journal of Hepato-Biliary-Pancreatic Sciences · 2026-07 · 33 (7) · 557-567
DOI: 10.1002/jhbp.70109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, online erschienen am 29.03.2026. Verfasst von Yasuhiro Kuraishi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shinshu University Hospital, Matsumoto, Japan. Hauptthemen laut MEDLINE: Autoimmune Pancreatitis, Adrenal Cortex Hormones. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background/Purpose Although type 1 autoimmune pancreatitis (AIP) responds well to corticosteroids, spontaneous remission can also occur. This study evaluated long‐term outcomes and predictors of delayed steroid initiation in AIP patients initially managed conservatively.
Methods
Type 1 AIP patients diagnosed between 2003 and 2024 were retrospectively reviewed. Patients not receiving corticosteroids within 6 months of diagnosis were defined as initially untreated. The primary outcome was cumulative steroid initiation, with secondary outcomes including spontaneous remission and relapse. Predictors were analyzed using Cox proportional hazards models.
Results
Among 193 AIP patients, 62 were initially untreated and followed for a median of 94 months. Seventeen (24%) eventually required corticosteroids, with a 5‐year cumulative incidence of 33%. Multivariate analysis identified that elevated serum IgG4 independently predicted subsequent steroid initiation (hazard ratio [HR] 5.26, p = 0.009), whereas spontaneous remission was protective (HR 0.26, p = 0.013). Spontaneous remission occurred in 63% (4‐year cumulative incidence, 65%) and was less frequent in diffuse pancreatic enlargement. Relapse occurred in 46% of remission cases (8‐year cumulative incidence, 59%), with renal involvement predicting recurrence.
Conclusions
Nearly one‐third of initially untreated AIP patients required corticosteroids during long‐term follow‐up. Elevated IgG4 predicted steroid initiation, while spontaneous remission indicated a reduced likelihood.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Shinshu University Hospital, Matsumoto, Japan.
ORCID-Profile: Yasuhiro Kuraishi, Takefumi Kimura
Zitieren
APA
Kuraishi, Y., Nakamura, A., Minamisawa, M., Yanagisawa, T., Yonekura, C., Sasaki, N., Imamura, S., Kimura, T., Iwaya, Y., & Nagaya, T. (2026). Long‐Term Outcomes and Predictors of Delayed Steroid Initiation in Type 1 Autoimmune Pancreatitis Initially Managed Without Corticosteroids. Journal of Hepato-Biliary-Pancreatic Sciences, 33(7), 557-567. https://doi.org/10.1002/jhbp.70109
Vancouver
Kuraishi Y, Nakamura A, Minamisawa M, Yanagisawa T, Yonekura C, Sasaki N, et al. Long‐Term Outcomes and Predictors of Delayed Steroid Initiation in Type 1 Autoimmune Pancreatitis Initially Managed Without Corticosteroids. Journal of Hepato-Biliary-Pancreatic Sciences. 2026;33(7):557-567. doi:10.1002/jhbp.70109
BibTeX
@article{Kuraishi2026,
author = {Kuraishi, Yasuhiro and Nakamura, Akira and Minamisawa, Masafumi and Yanagisawa, Takumi and Yonekura, Chinatsu and Sasaki, Nobukazu and Imamura, Shunsuke and Kimura, Takefumi and Iwaya, Yugo and Nagaya, Tadanobu},
title = {Long‐Term Outcomes and Predictors of Delayed Steroid Initiation in Type 1 Autoimmune Pancreatitis Initially Managed Without Corticosteroids},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2026},
volume = {33},
number = {7},
pages = {557--567},
doi = {10.1002/jhbp.70109}
}
EUVIMED